SIRT3 and B-cell chronic lymphocytic leukemia: As BCR signaling pathway has emerged as a key driver for the expansion of neoplastic B-cell clones and pathogenesis in several B-cell malignancies including CLL31, we explored if in vitro activation of BCR signal in primary CLL cells could also induce SIRT3 expression.